Related Experiment Videos
Developmental acquisition of type X collagen in the embryonic chick tibiotarsus
Insights
Type X collagen, crucial for bone development, appears in hypertrophic chondrocytes during chick embryonic development. Its distribution shifts from the mid-diaphysis towards the epiphyses as ossification progresses.
Area of Science:
- Developmental Biology
- Biochemistry
- Histology
Background:
- Type X collagen is a short-chain collagen found in hypertrophic cartilage.
- Its specific role and temporal-spatial distribution during skeletal development are not fully elucidated.
Purpose of the Study:
- To map the temporal and spatial distribution of type X collagen during chick tibiotarsus development.
- To correlate type X collagen expression with chondrocyte differentiation and ossification.
Main Methods:
- Immunohistochemistry using a monoclonal antibody (AC9) specific for type X collagen.
- Analysis of chick tibiotarsus from embryonic day 6 to 1 day posthatching.
Main Results:
- Type X collagen first detected at 7.5 days in the mid-diaphyseal primary ossification center.
- Expression extended towards epiphyses with embryonic age, lagging behind chondrocyte hypertrophy.
- A secondary epiphyseal site of deposition appeared at 19 days.
Conclusions:
- Type X collagen is specifically synthesized by hypertrophic chondrocytes in the developing chick limb bud.
- Its distribution pattern supports its role in endochondral ossification.
- Findings align with previous biochemical studies on type X collagen's function.
Abstract:
The temporal and spatial distribution of short chain skeletal (Type X) collagen was immunohistochemically examined in the chick tibiotarsus from 6 days of embryonic development to 1 day posthatching. The monoclonal antibody employed (AC9) was recently produced and characterized as being specific for an epitope located within the helical domain of the type X collagen molecule (T. M. Schmid and T. F. Linsenmayer, J. Cell Biol., in press). The earliest detectable appearance of type X collagen was at 7.5 days, at which time it was restricted to a middiaphyseal location (i.e., in the primary center of ossification). This was in marked contrast to type II collagen, which appears earlier and is distributed throughout the cartilaginous anlagen. With increasing embryonic age, the reactivity with the type X antibody progressively extended toward the epiphyses, lagging somewhat behind the progression of chondrocyte hypertrophy. The anti-type X collagen antibody also reacted with the bony matrix itself, but the immunofluorescent signal produced by this source was considerably less than that produced by cartilage. At 19 days of development, a new small site of type X deposition was initiated in an epiphyseal location, which subsequently enlarged in circumference. These results are consistent with our previous biochemical studies suggesting that, in cartilage, type X collagen is specifically a product of that population of chondrocytes which have undergone hypertrophy.